Valacyclovir Indications and Approved Uses

When clinicians choose it in pediatrics

Valacyclovir converts rapidly to acyclovir, offering improved bioavailability and simplified dosing for HSV and varicella-zoster therapy in older children.

Looking for the dose calculator or main medication overview? Return to the main Valacyclovir page.

Primary Indications

Use episodic high-dose therapy for cold sores, daily suppression for frequent HSV recurrences, and early treatment for high-risk varicella or zoster. Monitor renal function and hydration.

Recurrent HSV labialis (cold sores)

Primary Use

Adolescents 12 years and olderRandomized trialsFirst-lineLabelDermatologic

Best results occur when taken at the earliest tingling or burning.

How to use

Dosing at a glance: 2 g at onset and 2 g 12 hours later.
Dose at the first prodrome for best efficacy.
Discuss suppressive therapy if outbreaks are frequent.
Reinforce sun and lip protection to reduce triggers.

Monitoring & follow-up

Parameters:

Lesion healing
Hydration
Adherence to prodrome dosing

Evidence Sources

Valacyclovir Label(2024)

Sexually Transmitted Infections Treatment Guidelines - Herpes(2024)

Chronic HSV suppression

Primary Use

Children and adolescentsClinical trialsFirst-lineGuidelineDermatologic

Counsel on condom use and disclosure even with suppression.

How to use

Dosing at a glance: Off-label under 18 years (the label does not establish genital herpes use in patients under 18). Adult label suppression is 500 mg to 1 g once daily.
Counsel on transmission risk despite suppression.

Monitoring & follow-up

Parameters:

Outbreak frequency
Renal function
Adherence to suppression

Monitor / follow-up

Reassess every 6-12 months to evaluate continued need.
Monitor renal function annually and adjust dosing if needed.

Evidence Sources

Valaciclovir for viral infections(2024)

Sexually Transmitted Infections Treatment Guidelines - Herpes(2024)

Varicella-zoster treatment

Primary Use

Children and adolescentsModerateGuidelineGuidelineDermatologic

Consider IV acyclovir for severe or immunocompromised cases.

How to use

Dosing at a glance: Chickenpox: 20 mg/kg per dose (max 1 g) three times daily for 5 days, ages 2 to under 18 (label). Zoster: adult dose 1 g three times daily for 7 days; not established under 18 years.
Use in high-risk children and adolescents when started within 24 hours of rash onset.
Ensure hydration and adjust dosing for renal impairment.

Monitoring & follow-up

Parameters:

Rash progression
Hydration status
Neurologic symptoms

Monitor / follow-up

Monitor for neurologic involvement in zoster.

Evidence Sources

Clinical Overview of Varicella(2024)

Clinical Practice Guideline for the Management of Herpes Zoster(2016)

Secondary Clinical Uses

HSV-associated erythema multiforme prophylaxis

Secondary Use

Children and adolescentsExpert opinionSecond-lineConsensusSkin

Coordinate dermatology follow-up for taper plans.

How to use

Dosing at a glance: 500 mg once or twice daily for 6 months, then reassess.
Track lesion flares with photos and diaries.
Reassess after 6 months for taper or alternate therapy.
Provide rescue plans for breakthrough episodes.

Monitoring & follow-up

Parameters:

Breakthrough flares
Adherence
Side effects

Evidence Sources

Erythema Multiforme(2024)

Post-exposure prophylaxis for high-risk varicella contacts

Secondary Use

Immunocompromised adolescentsSpecialist consensusAdjunctGuidelineImmune

Consult infectious disease for immunocompromised hosts.

How to use

Dosing at a glance: 20 mg/kg/dose three times daily (max 1,000 mg/dose; max 3,000 mg/day) for 7 days, starting 7–10 days after exposure (JPIDS 2024 review).
Use when VZIG is unavailable or delayed.
Document immunity status and plan vaccination when eligible.

Monitoring & follow-up

Parameters:

Rash development
Fever
Hydration status

Monitor / follow-up

Monitor for rash and escalate to IV acyclovir if infection develops.

Evidence Sources

Clinical Overview of Varicella(2024)

Varicella post-exposure prophylaxis review (Journal of the Pediatric Infectious Diseases Society)(2024)

Off-Label Uses

Note: Off-label uses may be clinically appropriate based on evidence and expert consensus, but are not FDA-approved for these indications. Always consider the evidence base and document clinical reasoning.

Cytomegalovirus prophylaxis in renal transplant recipients

Off-Label

AdolescentsClinical trialsOff-labelOff-labelImmune

Reserve for valganciclovir intolerance.

How to use

Dosing at a glance: 2 g four times daily in select protocols.
Use only under transplant infectious disease guidance.
Switch to valganciclovir when tolerated.

Monitoring & follow-up

Parameters:

CBC and renal function
GI tolerance
Signs of CMV breakthrough

Monitor / follow-up

Monitor CBC and renal function closely.

Evidence Sources

Valacyclovir for CMV Prophylaxis in Pediatric Renal Transplant(2022)

Clinical Decision Support

When to start therapy

HSV prodrome or frequent recurrences requiring suppression.
High-risk varicella or zoster when started early.
Specialist-directed prophylaxis in immunocompromised hosts.

Triage questions

Is renal function adequate for dosing?
Is the patient immunocompromised or pregnant?
Can the family recognize prodrome symptoms?

Consult triggers

Suspected antiviral resistance or breakthrough disease.
Need for IV therapy (encephalitis or disseminated zoster).
Pregnancy in adolescents with HSV.

When to Reassess

Timeframe: 6-12 months for suppression or sooner if symptoms persist

Key criteria to review:

Breakthrough outbreaks
Renal function decline
Adverse effects

Next steps: Adjust dosing, confirm adherence, or consider alternative antivirals.

Care & Monitoring Highlights

Monitoring priorities

Baseline renal function and hydration status.
Assess for neurologic symptoms in high-dose therapy.
Review outbreak logs annually for suppressive therapy.

Caregiver counseling

Valacyclovir lowers but does not eliminate HSV transmission.
Ensure adequate hydration during therapy.
Do not share medication with others.

By Age Group

children

Selected varicella treatment
HSV suppression under specialist guidance

adolescents

Cold sore episodic therapy
HSV suppression
Varicella prophylaxis when high risk

Alternative Medication Options

Acyclovir

Alternative

Younger children needing liquid formulations

Advantages

More pediatric data

Disadvantages

More frequent dosing

Famciclovir

Alternative

HSV suppression in teens with valacyclovir intolerance

Advantages

Alternative agent

Disadvantages

Tablet only

Valganciclovir

Alternative

CMV prophylaxis

Advantages

Preferred CMV agent

Disadvantages

Cytopenia risk

Parent Communication Guide

When This Medicine Helps

Understanding the Condition

Valacyclovir treats herpes viruses and helps shorten outbreaks.

Why We Choose This Medicine

It is easier to take than acyclovir and helps reduce outbreaks.

What to Expect

Most children improve within a few days if taken early.

Monitoring Your Child

Signs the Medicine is Working:

Shorter outbreaks
Less pain or itching
Fewer recurrences

When to Contact Your Doctor:

No improvement after: No improvement after the expected treatment window

Watch for these warning signs:

Confusion or agitation
Severe dehydration
New widespread rash

What to do: Seek urgent care and contact the care team for severe symptoms.

Common Parent Questions

Should we start at the first tingling?

Yes, early dosing works best.

Does it prevent transmission?

It lowers but does not eliminate risk.

What if we miss a dose?

Give it when you remember unless it is close to the next dose. Do not double up.

Key messages for families

Start early at the first sign of outbreak.
Hydrate well during therapy.
Call for confusion or severe dehydration.

Home care tips

Keep outbreak logs and triggers.
Track urine output during febrile illness.
Use sunscreen to reduce HSV triggers.

Never Use Valacyclovir For

Empiric treatment of nonspecific rashes without HSV or VZV suspicion.

Alternatives: Consult prescribing references for suitable substitutes.

Infants younger than label age without specialist guidance.

Alternatives: Consult prescribing references for suitable substitutes.

Patients with untreated severe dehydration or acute kidney injury.

Alternatives: Consult prescribing references for suitable substitutes.

Last updated: 2/27/2026•Evidence quality: 86/10

Back to Overview

References

Valacyclovir LabelDailyMed, 2024https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7696a2e0-c7f9-47a0-a7d3-d14fd9301be8
Sexually Transmitted Infections Treatment Guidelines - HerpesCenters for Disease Control and Prevention, 2024https://www.cdc.gov/std/treatment-guidelines/herpes.htm
Valaciclovir for viral infectionsMedicines for Children, 2024https://www.medicinesforchildren.org.uk/medicines/valaciclovir-for-viral-infections/
Varicella post-exposure prophylaxis review (Journal of the Pediatric Infectious Diseases Society)Journal of the Pediatric Infectious Diseases Society, 2024https://academic.oup.com/jpids/article/13/1/69/7439837
Clinical Overview of VaricellaCenters for Disease Control and Prevention, 2024https://www.cdc.gov/chickenpox/hcp/clinical-overview.html
Clinical Practice Guideline for the Management of Herpes ZosterInfectious Diseases Society of America, 2016https://www.idsociety.org/practice-guideline/herpes-zoster/
Erythema MultiformeStatPearls, 2024https://www.ncbi.nlm.nih.gov/books/NBK482338/
Valacyclovir for CMV Prophylaxis in Pediatric Renal TransplantPediatric Transplantation, 2022https://doi.org/10.1111/petr.14080

Peds CalcSimple and Safe Pediatric Dosing Tools

PedsCalc Pro

Get the installable pediatric calculator app.

149 tools, 65 medication dose calculators, local notes, quick history, and a home-screen web app.

Open app Install

Back to Valacyclovir Overview

Valacyclovir Indications and Approved Uses

When clinicians choose it in pediatrics

Valacyclovir converts rapidly to acyclovir, offering improved bioavailability and simplified dosing for HSV and varicella-zoster therapy in older children.

Looking for the dose calculator or main medication overview? Return to the main Valacyclovir page.

Primary Indications

Use episodic high-dose therapy for cold sores, daily suppression for frequent HSV recurrences, and early treatment for high-risk varicella or zoster. Monitor renal function and hydration.

Recurrent HSV labialis (cold sores)

Primary Use

Adolescents 12 years and olderRandomized trialsFirst-lineLabelDermatologic

Best results occur when taken at the earliest tingling or burning.

How to use

Dosing at a glance: 2 g at onset and 2 g 12 hours later.
Dose at the first prodrome for best efficacy.
Discuss suppressive therapy if outbreaks are frequent.
Reinforce sun and lip protection to reduce triggers.

Monitoring & follow-up

Parameters:

Lesion healing
Hydration
Adherence to prodrome dosing

Evidence Sources

Valacyclovir Label(2024)

Sexually Transmitted Infections Treatment Guidelines - Herpes(2024)

Chronic HSV suppression

Primary Use

Children and adolescentsClinical trialsFirst-lineGuidelineDermatologic

Counsel on condom use and disclosure even with suppression.

How to use

Dosing at a glance: Off-label under 18 years (the label does not establish genital herpes use in patients under 18). Adult label suppression is 500 mg to 1 g once daily.
Counsel on transmission risk despite suppression.

Monitoring & follow-up

Parameters:

Outbreak frequency
Renal function
Adherence to suppression

Monitor / follow-up

Reassess every 6-12 months to evaluate continued need.
Monitor renal function annually and adjust dosing if needed.

Evidence Sources

Valaciclovir for viral infections(2024)

Sexually Transmitted Infections Treatment Guidelines - Herpes(2024)

Varicella-zoster treatment

Primary Use

Children and adolescentsModerateGuidelineGuidelineDermatologic

Consider IV acyclovir for severe or immunocompromised cases.

How to use

Dosing at a glance: Chickenpox: 20 mg/kg per dose (max 1 g) three times daily for 5 days, ages 2 to under 18 (label). Zoster: adult dose 1 g three times daily for 7 days; not established under 18 years.
Use in high-risk children and adolescents when started within 24 hours of rash onset.
Ensure hydration and adjust dosing for renal impairment.

Monitoring & follow-up

Parameters:

Rash progression
Hydration status
Neurologic symptoms

Monitor / follow-up

Monitor for neurologic involvement in zoster.

Evidence Sources

Clinical Overview of Varicella(2024)

Clinical Practice Guideline for the Management of Herpes Zoster(2016)

Secondary Clinical Uses

HSV-associated erythema multiforme prophylaxis

Secondary Use

Children and adolescentsExpert opinionSecond-lineConsensusSkin

Coordinate dermatology follow-up for taper plans.

How to use

Dosing at a glance: 500 mg once or twice daily for 6 months, then reassess.
Track lesion flares with photos and diaries.
Reassess after 6 months for taper or alternate therapy.
Provide rescue plans for breakthrough episodes.

Monitoring & follow-up

Parameters:

Breakthrough flares
Adherence
Side effects

Evidence Sources

Erythema Multiforme(2024)

Post-exposure prophylaxis for high-risk varicella contacts

Secondary Use

Immunocompromised adolescentsSpecialist consensusAdjunctGuidelineImmune

Consult infectious disease for immunocompromised hosts.

How to use

Dosing at a glance: 20 mg/kg/dose three times daily (max 1,000 mg/dose; max 3,000 mg/day) for 7 days, starting 7–10 days after exposure (JPIDS 2024 review).
Use when VZIG is unavailable or delayed.
Document immunity status and plan vaccination when eligible.

Monitoring & follow-up

Parameters:

Rash development
Fever
Hydration status

Monitor / follow-up

Monitor for rash and escalate to IV acyclovir if infection develops.

Evidence Sources

Clinical Overview of Varicella(2024)

Varicella post-exposure prophylaxis review (Journal of the Pediatric Infectious Diseases Society)(2024)

Off-Label Uses

Cytomegalovirus prophylaxis in renal transplant recipients

Off-Label

AdolescentsClinical trialsOff-labelOff-labelImmune

Reserve for valganciclovir intolerance.

How to use

Dosing at a glance: 2 g four times daily in select protocols.
Use only under transplant infectious disease guidance.
Switch to valganciclovir when tolerated.

Monitoring & follow-up

Parameters:

CBC and renal function
GI tolerance
Signs of CMV breakthrough

Monitor / follow-up

Monitor CBC and renal function closely.

Evidence Sources

Valacyclovir for CMV Prophylaxis in Pediatric Renal Transplant(2022)

Clinical Decision Support

When to start therapy

HSV prodrome or frequent recurrences requiring suppression.
High-risk varicella or zoster when started early.
Specialist-directed prophylaxis in immunocompromised hosts.

Triage questions

Is renal function adequate for dosing?
Is the patient immunocompromised or pregnant?
Can the family recognize prodrome symptoms?

Consult triggers

Suspected antiviral resistance or breakthrough disease.
Need for IV therapy (encephalitis or disseminated zoster).
Pregnancy in adolescents with HSV.

When to Reassess

Timeframe: 6-12 months for suppression or sooner if symptoms persist

Key criteria to review:

Breakthrough outbreaks
Renal function decline
Adverse effects

Next steps: Adjust dosing, confirm adherence, or consider alternative antivirals.

Care & Monitoring Highlights

Monitoring priorities

Baseline renal function and hydration status.
Assess for neurologic symptoms in high-dose therapy.
Review outbreak logs annually for suppressive therapy.

Caregiver counseling

Valacyclovir lowers but does not eliminate HSV transmission.
Ensure adequate hydration during therapy.
Do not share medication with others.

By Age Group

children

Selected varicella treatment
HSV suppression under specialist guidance

adolescents

Cold sore episodic therapy
HSV suppression
Varicella prophylaxis when high risk

Alternative Medication Options

Acyclovir

Alternative

Younger children needing liquid formulations

Advantages

More pediatric data

Disadvantages

More frequent dosing

Famciclovir

Alternative

HSV suppression in teens with valacyclovir intolerance

Advantages

Alternative agent

Disadvantages

Tablet only

Valganciclovir

Alternative

CMV prophylaxis

Advantages

Preferred CMV agent

Disadvantages

Cytopenia risk

Parent Communication Guide

When This Medicine Helps

Understanding the Condition

Valacyclovir treats herpes viruses and helps shorten outbreaks.

Why We Choose This Medicine

It is easier to take than acyclovir and helps reduce outbreaks.

What to Expect

Most children improve within a few days if taken early.

Monitoring Your Child

Signs the Medicine is Working:

Shorter outbreaks
Less pain or itching
Fewer recurrences

When to Contact Your Doctor:

No improvement after: No improvement after the expected treatment window

Watch for these warning signs:

Confusion or agitation
Severe dehydration
New widespread rash

What to do: Seek urgent care and contact the care team for severe symptoms.

Common Parent Questions

Should we start at the first tingling?

Yes, early dosing works best.

Does it prevent transmission?

It lowers but does not eliminate risk.

What if we miss a dose?

Give it when you remember unless it is close to the next dose. Do not double up.

Key messages for families

Start early at the first sign of outbreak.
Hydrate well during therapy.
Call for confusion or severe dehydration.

Home care tips

Keep outbreak logs and triggers.
Track urine output during febrile illness.
Use sunscreen to reduce HSV triggers.

Never Use Valacyclovir For

Empiric treatment of nonspecific rashes without HSV or VZV suspicion.

Alternatives: Consult prescribing references for suitable substitutes.

Infants younger than label age without specialist guidance.

Alternatives: Consult prescribing references for suitable substitutes.

Patients with untreated severe dehydration or acute kidney injury.

Alternatives: Consult prescribing references for suitable substitutes.

Last updated: 2/27/2026•Evidence quality: 86/10

Back to Overview

References

Valacyclovir LabelDailyMed, 2024https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7696a2e0-c7f9-47a0-a7d3-d14fd9301be8
Sexually Transmitted Infections Treatment Guidelines - HerpesCenters for Disease Control and Prevention, 2024https://www.cdc.gov/std/treatment-guidelines/herpes.htm
Valaciclovir for viral infectionsMedicines for Children, 2024https://www.medicinesforchildren.org.uk/medicines/valaciclovir-for-viral-infections/
Varicella post-exposure prophylaxis review (Journal of the Pediatric Infectious Diseases Society)Journal of the Pediatric Infectious Diseases Society, 2024https://academic.oup.com/jpids/article/13/1/69/7439837
Clinical Overview of VaricellaCenters for Disease Control and Prevention, 2024https://www.cdc.gov/chickenpox/hcp/clinical-overview.html
Clinical Practice Guideline for the Management of Herpes ZosterInfectious Diseases Society of America, 2016https://www.idsociety.org/practice-guideline/herpes-zoster/
Erythema MultiformeStatPearls, 2024https://www.ncbi.nlm.nih.gov/books/NBK482338/
Valacyclovir for CMV Prophylaxis in Pediatric Renal TransplantPediatric Transplantation, 2022https://doi.org/10.1111/petr.14080